Human lymphocytes assay: cyclophosphamide metabolic activation by S9 system with low cytotoxicity.
The general suitability of exposing human lymphocytes directly to prolonged contact with an Ames-type microsomal (S9) activation system has been examined, for testing the effect of the indirect chemical mutagen, cyclophosphamide (CPA), on induction of chromosomal aberrations. Direct exposure of lymphocytes to only S9 mix produced a decrease in the mitotic index within 30-60 min, whereafter it stabilized at acceptable values. Further toxic effects following treatment with different doses of CPA and S9 mix, for the longest times of exposure were due to production of clastogenic metabolites. On the basis of these results, the low cytotoxicity of S9 mix in our conditions allows extension of the application of the test to the study of metabolites which require prolonged contact with the target cells.
D000818:Animals; D001711:Biotransformation; D002470:Cell Survival / Q000187:drug effects; D002869:Chromosome Aberrations; D003520:Cyclophosphamide / Q000378:metabolism* / Q000633:toxicity; D007399:Interphase / Q000187:drug effects; D008214:Lymphocytes / Q000187:drug effects*; D008297:Male; D051379:Mice; D008862:Microsomes, Liver / Q000378:metabolism; D008938:Mitosis / Q000187:drug effects; D009152:Mutagenicity Tests; D009154:Mutation / Q000187:drug effects
D003520:Cyclophosphamide